Gil Hevroni, M.D.

Myeloma & amyloid doctor @univmiami @SylvesterCancer #Hematology#Oncology #mama #catmama

[OncoDaily @oncodaily]

Sylvester Names 2026 K12 Calabresi Scholars in Cancer Research and Clinical Trials

@SylvesterCancer @GilHevroni

https://t.co/V6DUInoZnR

[Gil Hevroni, M.D. @GilHevroni]

#ASCO2026 #support #cancerresearch #innovation

[Sylvester Comprehensive Cancer Center @SylvesterCancer]

New research led by Dr. Gerald Soff was presented at @ASCO, which suggests the oral medication avatrombopag may help patients with gastrointestinal cancers avoid chemotherapy delays caused by low platelet counts. 🙌

In a phase 2 clinical trial, avatrombopag demonstrated strong effectiveness in treating chemotherapy-induced thrombocytopenia (CIT). Learn more: https://t.co/nhKTGzFtbJ. #GIcancer #Hematology

[Gil Hevroni, M.D. @GilHevroni]

So grateful to be part of such a dedicated team and discuss
important strides In #MultipleMyeloma #MMawarenessmonth @SylvesterCancer

[Rafat Abonour @rabonour1]

Today is great day in the journey to cure myeloma. Thank you to all the brave patients signing up to this amazing trial

[BlackSabbath @BlackSabbath]

Ozzy Forever!

[Israel ישראל @Israel]

This is for Kfir and Ariel.

Share this 🟧 in support of the Bibas family.

May their memory be a blessing.

[Miami Hem/Onc Program Director @HemOncMiami]

Starting 2025 with warmth, laughter, and great company! 🥂🎉 Grateful for a sunny breakfast brunch at our home, celebrating new beginnings with @SylvesterCancer Hem/Onc fellowship family. Cheers to a year of growth and camaraderie! @Maryam_Alasfour @MichaelDurante1

[Sylvester Comprehensive Cancer Center @SylvesterCancer]

Our researchers are redefining #myeloma care with immunotherapy & precision medicine. Learn how the Sylvester Myeloma Research Institute, led by @DrOlaLandgren is adapting to a field transformed by new #immunotherapy drugs and therapies: https://t.co/hpDASdkkzY 🔬 #ASH24 #MMSM

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

Almost every review I've ever read about myeloma #MMsm starts with something (true) like, "Recent advances in myeloma have led to significant improvements in..."

Quite a jolt to see how different the prognosis was for myeloma 60 years ago... and how these papers used to begin!

[Gil Hevroni, M.D. @GilHevroni]

Check out this review on myeloma precursor states:

From MGUS to multiple myeloma: Unraveling the unknown of precursor sta... https://t.co/MibctGAJ6Z

Thank you @DrOlaLandgren @Drjhoffmanmiami, @davidcoffey and the myeloma team for the mentorship and support 🙌 @SylvesterCancer

[Gil Hevroni, M.D. @GilHevroni]

Inspirational!

[Gil Hevroni, M.D. @GilHevroni]

Celebrating happy moments and amazing NP Suzan in #myeloma #amyloid Wednesday! @SylvesterCancer

[Gil Hevroni, M.D. @GilHevroni]

@liviiilevine So proud of you!!

[Gil Hevroni, M.D. @GilHevroni]

Eden had a sensational performance in Sweden today #Eurovision2024. In awe of her courage and talent.

[Multiple Myeloma RF @theMMRF]

Today, US FDA held an ODAC meeting to debate MRD as an endpoint to support accelerated approval in #myeloma clinical trials. Two groups (@SylvesterCancer and i2TEAMM) presented retrospective data from clinical trials that measured MRD. Final vote was 12-0 in favor.

[International Myeloma Foundation @IMFmyeloma]

IMF celebrates ODAC's historic decision on MRD testing as an early endpoint for accelerated myeloma drug approval. 10 yrs of IMF research led by Dr. Durie & i2TEAMM; & U of Miami Sylvester Comprehensive Cancer Center contributed to this decision. @BrunoPaiva_UNAV @NikhilMunshiMD

[CABOMETYX® (cabozantinib) HCP @CABOMETYX]

CABOMETYX shows significant reduction in risk of progression or death in patients with locally advanced/metastatic DTC that has progressed following VEGFR-targeted therapy and who are RAI-R or ineligible.¹ Visit https://t.co/r9YDWdNnJR for full Prescribing Info.

[Gil Hevroni, M.D. @GilHevroni]

A great #myeloma #amyloid Wednesday clinic celebrating @Drjhoffmanmiami birthday 🎉 @SylvesterCancer #dreamteam 🙌 🩸 #hemeteam

[Gil Hevroni, M.D. @GilHevroni]

My best friend is coming to UMiami for urogyn! ♥️

[Katie Amin, MD, FPMRS, FACS, FRCS @KatherineAminMD]

We’re so thrilled to announce and welcome superstars:

🌟 Amy Wu (Urology) from @TexasTech &

🌟 Tamar Yacoel (Ob-Gyn) from @HMHNewJersey

as our incoming #FPMRS & #UroGyn fellows for 2024! #Match2024 @dsui_miami_uro